INTRODUCTION
============

Spirometry is a simple diagnostic tool based on the measurement of respiratory airflow. Its main use remains in screening and diagnosis of airflow obstruction which is characterized by a low ratio of forced expiratory volume exhaled in one second (FEV1) to the forced vital capacity (FVC) \[[@R1]\]. However, it can also help to exclude restriction when the FVC is normal \[[@R2]-[@R4]\].

A common scenario that arises in routine spirometry is when both the ratio of FEV1/FVC and FVC are below the lower limits of normal. This can represent what has been described as "mixed abnormality", which is characterized by the coexistence of obstruction and restriction in a person \[[@R5]\]. In the presence of airways obstruction, it is a well known fact that the FVC can be low due to air trapping \[[@R6]\]. This air trapping is the cause of the "mixed abnormality" in 87% of such cases and only approximately 10% of the cases have true restriction \[[@R3],[@R7]\]. This observation is supported by the fact that even in patients who have a typical restrictive pattern (normal or high normal FEV1/FVC ratio and low FVC), spirometry only has a sensitivity of approximately 68% and positive predictive value of about 58% in diagnosing true restriction when compared to total lung capacity (TLC) \[[@R2],[@R3]\]. ATS/ERS guidelines state that when FVC is low, presence of a restrictive component in an obstructed patient cannot be inferred from simple measurement of FEV1 and FVC \[[@R4]\]. In those patients, measurement of TLC is necessary to exclude restriction \[[@R2],[@R4]\]. Diagnosis of restriction is made by a reduction of TLC below the 95 percent confidence interval of normal of the predicted value for an individual \[[@R4]\].

Lung volumes can be measured by helium-dilution method, nitrogen wash out method or plethysmography/body box method \[[@R5]\]. These are usually available in licensed pulmonary function labs and primarily ordered to diagnose restrictive pulmonary impairment \[[@R6]\]. Average cost of measuring lung volumes in United States is about \$288 \[[@R3]\]. The performance of lung volumes in all patients with obstruction and a low FVC obviously consumes resources and time. Thus, it would be useful to be able to limit lung volume testing by excluding patients at low risk for concomitant restriction.

Glady *et al.*previously developed an algorithm that suggested the need for TLC measurement if the forced vital capacity (FVC) was \<85% of predicted and the ratio of FEV1/FVC was \>55% \[[@R2]\]. Their algorithm had a high sensitivity to predict restriction and a high negative predictive value to exclude restriction. However, their study population included all comers for spirometry and did not specifically test the patient population with a low FVC in the presence of a reduced FEV1/FVC ratio. Another algorithm was proposed by Swanney *et al.*, but they also did not specifically test this subgroup of patients \[[@R8]\].

The goal of our study was to formulate a tool to exclude restriction specifically in patients who show both obstruction and a low FVC on spirometry (for whom TLC measurement is recommended by ATS/ERS 2005 guidelines) and compare the validity of the tool with the one proposed by Glady *et al*.

METHODS
=======

Study Population
----------------

This study was reviewed and approved by the hospital's Institutional Review Board. We queried our database for all patients who underwent complete pulmonary function test evaluation at the Pulmonary Laboratory at a tertiary care teaching hospital between January 1, 2002 and December 31, 2004. A complete pulmonary function test evaluation included spirometry and a total lung volume measurement performed on the same day, as ordered by the referring physician. Studies were collected for further analysis if they showed obstruction and a low FVC. Obstruction was defined by a FEV1/FVC ratio less than the lower limit of normal (LLN) of the predicted value for this ratio using the third National Health and Nutrition Examination Survey (NHANES III) criteria \[[@R9]\]. The LLN was defined as the lower 95% confidence limit of normal i.e., 1.645 times the standard deviation below the mean predicted reference value \[[@R9]\]. A low FVC was defined as a FVC that met one of two criteria; either less than the lower 95% confidence limit of normal (1.645 x SD below the mean) or \<75% of predicted (to account for shorter, aged individuals whose lower confidence limit would be artificially markedly reduced). The TLC lower limits of normal were defined as with the FVC. The lower 95% confidence limit from the mean was used (adjusting for racial differences based on ATS/ERS guidelines 2005 guidelines), again using an absolute lower limit of normal of 75% of predicted to account for the excessively large errors caused in aged elderly patients \[[@R10]\]. We excluded patients younger than 18 years old, and those who did not complete the tests. We only included the first study if the same patient had two or more tests during the study period. For those studies where a bronchodilator was used, we only considered the pre-bronchodilator variables for analysis purposes.

Methodology
-----------

Pulmonary function tests were performed according to the ATS/ERS publications for spirometry, plethysmography, and nitrogen washout \[[@R11]-[@R13]\]. The data was obtained using Viasys Legacy and Spectra pulmonary function systems. Lung function testing equipment was calibrated daily using a 3 liter syringe. TLC was measured by both body plethysmography and nitrogen washout, taking the higher of the 2 values using the Residual Volume (RV) + Vital Capacity (VC) method. The pressure transducer for plethysmography was calibrated daily with a 50 ml pump operating at approximately 2 Hz to ascertain the accuracy of the pressure deflections, and nitrogen washout was calibrated using two gas concentrations of 100% oxygen and a mixture of 16% O2, 4% CO2 and 80% N2. Biologic controls were also performed monthly.

Variables
---------

We collected the following data for analysis: sex, age, race, forced expiratory volume in the first second (FEV~1~), forced expiratory volume in the first six seconds (FEV~6~), forced expiratory flow between 25-75% (FEF 25-75), FVC, Slow Vital Capacity (SVC), and TLC. We also recorded the predicted values for all these variables and when pertinent, the observed value divided by the predicted value which was then multiplied by 100 to obtain the percent predicted (% pred).

Study Groups
------------

All the studies which satisfied our criteria were randomly divided into two groups of approximately equal size. One group was used to derive a formula to predict the absence of restriction. This group was labeled as "derivation group". The remaining patients were then used to test the predictive formula and were labeled "validation group".

Statistical Analysis
--------------------

We studied only those patients with concomitant obstruction and a low FVC. These patients were divided into two groups depending whether or not restriction was present, as evidenced by a low TLC. The student-t test was used to compare all continuous variables for differences between patients with and without restriction. The chi-square test was used to compare nominal variables.

Using only the derivation group, a stepwise logistic regression analysis was used to find those factors that were independently associated with restriction. The variables that were investigated included all the ones mentioned above as well as combined variables felt to be potentially revealing by the authors. The four combined variables that were investigated included: (FEV~1~/FVC)/FVC % pred, (FEV~1~/FVC) % pred/FVC % pred, (FEV~1~/FEV~6~)/FVC % pred, and (FEV~1~/ FEV~6~) % pred/FVC % pred. Sample calculation based on an actual spirometric analysis is shown in Table **[1](#T1){ref-type="table"}**.

Logistic regression was used to discover the variable with the strongest association to TLC. This was done by doing stepwise logistic regression to find the variable with the best predictive power. Multiple cut points of the predictor variable were then evaluated in a series of two-by-two tables to determine the optimal value to maximize sensitivity while maintaining a reasonable specificity. A final two-by-two table was then created based on our formula to calculate the sensitivity, specificity, positive predictive value (PPV), and negative predicted value (NPV) in the derivation group.

We then used a validation group as an independent cohort to test the validity of our model. We constructed another two-by-two table to calculate the sensitivity, specificity, PPV, and NPV in the validation cohort using the same predictive equation. The utility of this validated model was further assessed by comparing our results to Glady's published models for predictive equations \[[@R2]\]. We used an alpha level of 0.05 for all the analysis and all the analysis was performed using SAS®, Inc. software (Cary, North Carolina, USA).

RESULTS
=======

A total of 2812 patients had complete pulmonary function tests (spirometry, lung volumes and DLCO) in our laboratory during 2002. From those, 990 had a low vital capacity and an obstructive pattern on spirometry. A total of 154 (15.6%) patients in this group were found to have restriction. The characteristics of those patients with and without restriction are shown in Table **[2](#T2){ref-type="table"}**.

We then divided our study population into two groups by use of a random number generator. Thus, 473 studies were used to derive a predictive equation and labeled the "derivation group". Using logistic regression analysis in this group, we found many spirometric variables that were independently associated with restriction. These variables included: FVC, FEF~25-75~, FEV~6~, FEV~1~/FVC, FEV~1~/FEV~6~, FVC percent predicted, FEV~6~ percent predicted, FEF25-75 percent predicted, FEV~1~/FEV~6~percent predicted and FEV~1~/FVC percent predicted. All of the four combined variables described in the methods were independently associated with the presence of restriction as well. However, the variable that was most strongly correlated and the only one that remained when using stepwise regression was a ratio of two ratios, represented as the ratio of FEV~1~/FVC percent predicted divided by the FVC percent predicted \[(FEV~1~/FVC) % pred/FVC % pred\]. This variable was then further evaluated for its discriminative abilities. We were able to determine the value of 1.11 as the maximal cut point for specificity. Thus, a value of \[(FEV1/FVC) % pred/FVC % pred\] ≥1.11 would determine absence of restriction. Applying this cut off to our "derivation" group results in the outcome, as shown in Table **[3](#T3){ref-type="table"}**. Using this data, we find that the sensitivity, specificity, PPV, NPV were 95%, 42%, 25%, and 98% respectively.

We then validated our predictive equation in the remaining 517 patients. The discriminative formula was thus applied to this "validation group". When our formula was applied to this group, we found that our formula significantly predicted the absence of restriction (p\< 0.0001), with the results shown in Table **[4](#T4){ref-type="table"}**. In the validation group, the sensitivity, specificity, PPV, NPV were 95%, 44%, 22%, and 98%, respectively. Thus, both in our derivation and validation groups, our formula had a NPV of 98%.

To assess whether our formula had added utility over what has previously been published, we compared our results with those that would be obtained by applying the algorithm published by Glady *et al*. Using that formula, we were able to construct a two-by-two table in the validation group as shown in Table **[5](#T5){ref-type="table"}**. The sensitivity, specificity, PPV and NPV of the Glady algorithm were found to be 89%, 44%, 21% and 96%, respectively. The sensitivity and NPV, important to exclude restriction, were lower in Glady's algorithm compared to our formula. However, these differences could be simply due to the selection of a cut-off. Thus, we wanted to assess how the variables used in these formulas performed throughout the range of values in the entire data set. Thus, we constructed Receiver Operating Characteristics (ROC) Curves for our combined ratio \[(FEV~1~/FVC) % pred/FVC % pred\] (Fig. **[1](#F1){ref-type="fig"}**) and the ratio used by Glady *et al*. (Fig. **[2](#F2){ref-type="fig"}**) The ROC curve using our variable was more accurate with an area under the curve of 0.811 as compared to 0.713 for the variable used by Glady *et al*.

DISCUSSION
==========

This study shows that spirometry can be useful to exclude those patients with a low risk for restriction despite the presence of a low VC when obstruction is present.

The very high negative predictive value of spirometry shown in this study has a cost-saving implication, avoiding the need for further testing in a vast subset of patients. Based on our results 39% (200/517) of unnecessary total lung volume measurement could be avoided and we would still be able to diagnose 95% (71/75) of the patients with restriction.

Swanney *et al.*, in a recent study, compared their algorithm to one proposed by ATS and the one by Glady *et al*. \[[@R8]\]. However, their study population was different than ours and included all comers for spirometry as did the Glady's study, and did not specifically look at the study population that we used. Their formula was slightly inferior to Glady's formula in effectiveness as a screening tool to rule out restriction. We, therefore picked Glady's formula and applied to our study population to assess its effectiveness in this different cohort of patients.

When we applied Glady's algorithm to our study population, we found that our formula performed better based both on cutoffs and continuous assessment. Both sensitivity (95% *vs* 89%) and NPV (98% *vs* 96%) were found to be higher on our formula. Also, the variable performed better over the range of its values as shown by the area under the ROC curves (0.81 *vs* 0.71). Using Glady's algorithm we would avoid about the same number of tests (39%) but would only diagnose 136 of the 154 (89%) patients with restriction. Hence, we can conclude that compared to Glady's formula, our formula is a better screening test to rule out restriction in patients whose spirometry shows concomitant low FVC and obstruction. One, however, might argue that Glady's formula is preferable because it is much simpler than ours. If the calculation of the formula required a reader to calculate by hand while interpreting PFTs, one could see the lack of appeal. However, the values of our formula could easily be added to PFT softwares so that it would appear "automatically" on a spiromtry for a physician to interpret.

A prior study by Lefante *et al.*attempted to derive an equation to account for the effects of airflow obstruction on the observed FVC. They found that in patients with an FEV1/FVC ratio \<0.70, obstruction explained 15 to 17% of the variability in FVC percent predicted \[[@R14]\]. However, the formula used in a later study showed that such adjustment produced a 9% false negative rate \[[@R2]\]. With our formula, no such adjustment is warranted.

A limitation to our study could be that the decision to undergo for spirometry or a complete PFT, including TLC measurement, was not controlled. It could have been made by the referring physician possibly due to a higher clinical suspicion of restriction. This could raise the suspicion for ascertainment bias in this case. Actually a recent study looked into this dilemma and compared patients referred for spirometry alone and those referred for both spirometry and lung volume measurement \[[@R8]\]. They found the same frequency of a restrictive spirometric pattern in both groups, suggesting no significant ascertainment bias by the clinical selection of the physician for the test.

CONCLUSION
==========

Spirometry is a helpful tool that can be used to exclude the presence of restriction even in the presence of obstruction, limiting the expense of further testing while retaining sensitivity. The previously proposed tools to exclude restriction may not be that sensitive when utilized in patients with concomitant low FVC and obstruction. Our formula performs superior to the previously described algorithms.
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###### 

Calculations According to Different Investigated Formulas on a Sample Spirometry

  Spirometry   Variables       Measured Value   Reference Value   \% (Percent) Reference
  ------------ --------------- ---------------- ----------------- ------------------------
  FVC          Liters          2.83             4.07              70
  FEV1         Liters          1.68             3.05              55
  FEV1/FVC     \%              59.3             75.7              78
  FEV3         Liters          2.24             3.64              61
  FEV3/FVC     \%              79               88.4              89
  FEV6         Liters          2.55             3.88              66
  FEV1/FEV6    \%              66               79.2              83
  FEF25-75%    Liters/Second   0.55             2.51              22
  PEF          Liters/Second   4.38             8.36              52
  FET100%      Second          4.38             8.36              52

  Calculation of Investigated Variables:                          
  ------------------------------------------ -------------------- -------------------
  (FEV1/FVC)/FVC %predicted                  = 0.57/0.72 = 0.79   = 0.59/0.70= 0.84
  (FEV1/FVC) %predicted/FVC %predcited       = 0.76/0.72 = 1.06   = 0.78/0.70= 1.11
  (FEV1/FEV6)/FVC %predicted                 = 0.66/0.72 = 0.92   = 0.66/0.70= 0.94
  (FEV1/FEV6) % predcited/FVC %predcited     = 0.83/0.72 = 1.15   = 0.83/0.70= 1.18

**Abbreviations:** FVC (Forced Vital Capacity); FEV1 (Forced Expiratory Volume in 1 Second); FEV3 (Forced Expiratory Volume in 3 Seconds); FEV6 (Forced Expiratory Volume in 6 Seconds); FEF25-75% (Forced mid-expiratory flow rate); PEF (PeakExpiratory Flow); FET100% (Forced Expiratory Time).

###### 

Study Group Compared by the Presence or Absence of Restriction Based on TLC

  --------------------------------------------------------------------------------------------
  Characteristics                          Restriction\   No Restriction\   Significance (P)
                                           N = 154        N = 836           
  ---------------------------------------- -------------- ----------------- ------------------
  Age[†](#T2FN1){ref-type="fn"}            59.5 ± 14.9    61.3 ± 11.7       0.14

                                                                            

  Male sex (%)[‡](#T2FN2){ref-type="fn"}   75 (48.7)      392 (46.9)        0.68

                                                                            

  Race (%)                                                                  

   African-American                        70 (45.5)      262 (31.3)        0.003

   Caucasian                               83 (53.9)      570 (68.2)        

   Hispanic                                1 (0.7)        4 (0.5)           

                                                                            

  FEV1                                     1.23 ± 0.41    1.26 ±0.49        0.45

                                                                            

  VC                                       1.89 ± 0.58    2.26 ± 0.65       \<0.0001

                                                                            

  FEV6                                     1.77 ± 0.52    2.00 ± 0.59       \<0.0001

                                                                            

  FEF 25-75                                0.74 ± 0.46    0.61 ± 0.44       0.0007

                                                                            

  TLC                                      3.63 ± 0.75    5.67 ± 1.39       \<0.0001^\*^
  --------------------------------------------------------------------------------------------

All continuous variables are reported as mean ± standard deviation

In all cases, the percentage shown represents the column percentage for that value.

Abbreviations: FEV1: Forced Expiratory Volume in 1 Second; VC: Vital capacity; FEV6: Forced Expiratory Volume in 6 Seconds; FEF 25-75: Forced Mid-Expiratory Flow rate; TLC: Total Lung Capacity.

###### 

Two-by-Two Table of our Derivation Group Based on our Formula

                                           Restriction Present   Restriction Absent   Total
  ---------------------------------------- --------------------- -------------------- -------
  Formula suggests need to assess TLC      75                    230                  305
  Formula suggests no need to assess TLC   4                     164                  168
  Total                                    79                    394                  473

TLC recommended if (FEV1/FVC % pred)/FVC % pred \<1.11.

Abbreviations: TLC: Total Lung Capacity; FEV1: Forced Expiratory Volume in 1 Second; FVC: Forced Vital capacity.

###### 

Two-by-Two Table of the Validation Group Based on our Formula

                                           Restriction   No Restriction   Total
  ---------------------------------------- ------------- ---------------- -------
  Formula suggests need to assess TLC      71            246              317
  Formula suggests no need to assess TLC   4             196              200
  Total                                    75            442              517

TLC recommended if (FEV1/FVC % pred)/FVC % pred \<1.11.

Abbreviations: TLC: Total Lung Capacity; FEV1: Forced Expiratory Volume in 1 Second; FVC: Forced Vital capacity.

###### 

Two-by-Two Table of Study Group Based on Glady's Algorithm

                                           Restriction   No Restriction   Total
  ---------------------------------------- ------------- ---------------- -------
  Formula suggests need to assess TLC      67            248              315
  Formula suggests no need to assess TLC   8             194              202
  Total                                    75            442              517

TLC recommended if FVC\<85% of predicted and FEV1/FVC ≥55%

Abbreviations: TLC: Total Lung Capacity; FEV1: Forced Expiratory Volume in 1 Second; FVC: Forced Vital capacity.
